Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
Clinical trial NCT04519619 · RECRUITING
Trial details
- NCT number
- NCT04519619
- Sponsor
- Bayer
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2020-11-27
- Primary completion
- 2027-06-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.